HEAL Initiative: HEALthy Brain and Child Development (HBCD) Study (Collaborative U01- Clinical Trial Not Allowed)
ID: 358822Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Private Institutions of Higher Education

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358822
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative for the HEALthy Brain and Child Development (HBCD) Study, aimed at supporting research projects focused on participant recruitment, behavioral assessments, biospecimen collection, and neuroimaging. This initiative will involve a large cohort of approximately 7,200 pregnant women and their children, tracking their health and development over time, particularly in relation to exposure to various substances such as opioids and alcohol. The funding will be provided through a cooperative agreement, with an expected 27 awards available, and applications are anticipated to be solicited starting in July 2025, with a project start date set for July 1, 2026. For further inquiries, interested parties can contact Dr. Janani Prabhakar at janani.prabhakar@nih.gov or by phone at 301-827-4729.

    Point(s) of Contact
    Janani Prabhakar, PhD
    (301) 827-4729
    janani.prabhakar@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Limited Competition for the HEAL Initiative: HEALthy Brain and Child Development (HBCD) Study – Coordinating Administrative Core and Data Coordinating Center (U24 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a limited competition opportunity for the HEAL Initiative, specifically for the Coordinating Administrative Core (HCAC) and the Data Coordinating Center (HDCC) for the HEALthy Brain and Child Development (HBCD) study. This initiative aims to support a large cohort study involving approximately 7,200 pregnant women and their children, focusing on the effects of prenatal exposure to various substances, including opioids and alcohol, on child development. The selected applicants will be responsible for coordinating data collection, processing, and analysis, as well as managing the consortium's operations, with applications expected to be solicited in the future. Interested parties can reach out to Dr. Janani Prabhakar at janani.prabhakar@nih.gov or by phone at 301-827-4729 for further information, with key deadlines including an estimated synopsis close date of October 17, 2025, and an estimated award date of July 1, 2026.
    NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access." This initiative aims to provide researchers with access to biospecimens from significant studies, including the Adolescent Brain Cognitive Development (ABCD) Study and the HEALthy Brain and Child Development (HBCD) Study, to enhance understanding of the genetic and environmental factors influencing health and disease throughout life. The grant is open to a wide range of eligible applicants, including tribal governments, federal agencies, and foreign institutions, with no cost-sharing requirement. Interested parties should note that the estimated award date is January 4, 2027, and they can reach out to Heather L. Kimmel at heather.kimmel@nih.gov or by phone at 301-443-6504 for further information.
    Adult-Adolescent Brain Cognitive Development (A-ABCD) Study Renewal-Research Project Sites (U01)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) for the renewal of the Adult-Adolescent Brain Cognitive Development (A-ABCD) Study, specifically for research project sites under the U01 cooperative agreement mechanism. This initiative aims to continue the groundbreaking ABCD study, which is the largest long-term investigation of brain development and child and adolescent health in the U.S., by following the original cohort of nearly 12,000 participants into their emerging adulthood to assess various health outcomes. The study utilizes advanced technologies, including brain scans and wearable sensors, to explore how young adult experiences influence brain development and related social and health outcomes. Interested organizations that were funded through RFA-DA-20-002 are encouraged to prepare for this opportunity, with the estimated synopsis posting date on February 6, 2026, and a projected award date of April 1, 2027. For further inquiries, potential applicants can contact Dr. Bethany Deeds at deedsb@nida.nih.gov or by phone at 301-402-1935.
    Adult-Adolescent Brain Cognitive Development (A-ABCD) Study Renewal-Data Analysis, Informatics and Resource Center, and Coordinating Center (U24)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the renewal of the Adult-Adolescent Brain Cognitive Development (A-ABCD) Study, specifically for the Data Analysis, Informatics and Resource Center, and the Coordinating Center. This initiative aims to continue the longitudinal study of brain development and health outcomes in a cohort of nearly 12,000 participants, following them from childhood into emerging adulthood to assess the impact of various factors on their development. The study utilizes advanced technologies, including brain scans and wearable sensors, to explore how experiences during young adulthood influence health and behavioral outcomes. Interested applicants, particularly existing awardees under RFA-DA-20-004 and RFA-DA-20-003, should note that applications are not currently being solicited, but they can prepare for future submissions. For further inquiries, contact Bethany Deeds, PhD, at deedsb@nida.nih.gov or by phone at 301-402-1935. The estimated synopsis post date is February 6, 2026, with a projected award date of April 1, 2027.
    HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity under the HEAL Initiative, aimed at enhancing the implementation and sustainability of substance use preventive services. This initiative seeks to address the critical gaps between effective prevention research and its practical application, particularly in combating the opioid crisis, by soliciting applications for projects that demonstrate preliminary data and focus on strengthening prevention infrastructure. With approximately $4.65 million available for funding, grants can support projects for up to five years, with annual budget requests advised to remain under $800,000. Interested applicants must submit their proposals by January 16, 2026, and can find additional information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to release a Notice of Funding Opportunity (NOFO) titled "HEAL: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)" aimed at supporting research that translates addiction-related findings into practical applications to combat the opioid crisis and overdose events. This initiative seeks to identify and address factors influencing substance use and overdose deaths, focusing on developing effective, scalable interventions that integrate evidence-based practices into routine healthcare. Interested small businesses are encouraged to prepare for this opportunity, with applications expected to be solicited after the estimated synopsis post date of August 1, 2025, and closing on October 16, 2025. For further inquiries, potential applicants can contact Dr. Tisha Wiley at tisha.wiley@nih.gov or by phone at 301-594-4381.
    HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative, titled "Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)." This initiative aims to support early-stage translational research focused on developing and validating tests for non-opioid analgesics, including small molecules and biologics, to address the ongoing opioid crisis and improve pain management. The program anticipates a funding pool of $2.5 million, with plans to award approximately 4-5 grants in FY 2025, and applications are due by January 15, 2027. Interested applicants can find more information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity under the HEAL Initiative aimed at enhancing the implementation of preventive services for substance use disorders, specifically focusing on opioid misuse. This initiative invites applications for research that addresses gaps in the dissemination and implementation of prevention services, with a phased R61/R33 award mechanism allowing for up to six years of support, contingent on the successful completion of preliminary milestones. The overarching goal is to establish a sustainable prevention infrastructure that effectively reduces risks associated with substance use, emphasizing equity and community involvement in the research process. Interested applicants can find more information and apply by the deadline of January 16, 2026, with a projected funding amount of $4.65 million for the 2024 fiscal year. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-066.html.
    HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for the HEAL Initiative: Pain Management Effectiveness Research Network, specifically for Clinical Trial Planning and Implementation through a Cooperative Agreement (UG3/UH3). This initiative aims to conduct large-scale, multisite clinical trials that will evaluate the efficacy of interventions designed to reduce opioid use and improve pain management across various conditions, thereby enhancing functional outcomes for patients suffering from acute to chronic pain. The program is critical in expanding evidence-based therapeutic options for pain relief, benefiting patients and their families. Interested applicants, including various eligible entities such as tribal governments and community organizations, are encouraged to prepare for this opportunity, with applications expected to be solicited starting October 15, 2025, and closing on January 5, 2026. For further inquiries, potential applicants can contact Dr. Yolanda F. Vallejo at 301-451-1751 or via email at Yolanda.Vallejo@nih.gov.
    Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)" aimed at supporting research on strategies to prevent and intervene in fetal alcohol spectrum disorders (FASD). The initiative seeks proposals that focus on reducing prenatal alcohol exposure and improving interventions for individuals affected by FASD, utilizing the Exploratory/Developmental Phased Award (R61/R33) mechanism, which allows for pilot studies in the initial phase and potential expansion in the subsequent phase based on milestone achievements. This funding is crucial for addressing significant public health challenges related to prenatal alcohol exposure, with a total award ceiling of $350,000 and no cost-sharing requirements. Interested applicants must submit their proposals by January 16, 2024, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-068.html.